DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/ncrll6/global) has announced the addition of the "Global Intravenous Solutions Market 2014-2018" report to their offering.
The analysts forecasts the Global Intravenous Solutions market to grow with a CAGR of 7.88 percent for the period 2013-2018. Several driving factors and trends will contribute to this growth all of which will be outlined in detail in this report.
These analysts use a unique methodology to scrutinize individual vendor performance, trends, drivers, and challenges, and a number of other factors to provide the most accurate and detailed market research reports possible.
A more specific breakdown of this report's content has been listed below.
Commenting on the report, an analyst from the team said: Intravenous Vitamin C therapy has been shown to be effective against a wide variety of cancers. By intravenously injecting Vitamin C into a patient, it was observed that Ascorbate was able to generate a sufficient concentration of hydrogen peroxide and selectively kill cancer tissues through oxidative stress. Evidence has also been pointed out that a high dose of Vitamin C is very toxic for a variety of cancer cell lines. Six clinical trials testing Vitamin C, along with other chemotherapeutic drugs, are currently being conducted to determine their effectiveness in cancer treatment. If approved, the Vitamin C therapy delivered intravenously could be utilized to improve the quality of life for the patients afflicted with different types of cancer. Thus, the rising popularity of Vitamin C therapy administered intravenously, and its approval in clinical practice, could boost the growth of the overall Global Intravenous Solutions market during the forecast period.
According to the report, the increasing incidence of gastrointestinal disorders, diabetes, and cancer is one of the major factors that is driving the growth of the Global Intravenous Solutions market. Nearly 100 million Americans are affected by gastrointestinal disorders each year, and more than 350 million people globally, as of 2012, are affected by diabetes. Hence, the increasing incidences of gastrointestinal disorders, cancer, and diabetes are expected to increase the rate of adoption of intravenous solutions among consumers, driving the growth of the Global Intravenous Solutions market.
- Airwell Group
- Carrier Corp.
- Daikin Industries Ltd.
- Dwyer Instruments Inc.
- Gree Electric Appliances Inc.
- Haier Inc.
- Ingersoll-Rand plc
- Johnson Controls Inc.
- Lennox International Inc.
- LG Electronics Inc.
- Mitsubishi Electric Corp.
- Samsung Electronics Co. Ltd.
- Siemens AG
- Toshiba Corp.
- Voltas Ltd.
- Whirlpool Corp.
For more information visit http://www.researchandmarkets.com/research/ncrll6/global
About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.